Navigation Links
Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads
Date:5/15/2008

LLD EZ(TM) Provides Physicians with Flexibility and Control for Lead

Removal

COLORADO SPRINGS, Colo., May 15 /PRNewswire-FirstCall/ -- Spectranetics Corporation (Nasdaq: SPNC) today announced the availability of the new LLD EZ Lead Locking Device (LLD) for the removal of non-functional or infected pacing and defibrillation leads. The LLD EZ enables physicians to secure the entire lead creating traction to enable the removal process.

Management of implanted leads for pacemakers and defibrillators is a growing concern among physicians and patients since an increasing number of patients receive these devices at a relatively young age. Leads, or insulated wires that connect devices to the heart, may become non-functional or infected. When this occurs the primary treatment option is to remove the leads. Because scar tissue can bind the leads in several places along their length, specialized tools are needed to complete the removal process.

Spectranetics' LLD EZ provides a flexible solution to address the removal of leads from scar tissue holding them in place. LLD EZ employs a braided mesh that expands to secure leads along their hollow inner lumen permitting physicians to apply steady traction on the lead. The locking mechanism can be reversed, or unlocked, if the physician needs to remove the device from the lead or reposition it. The LLD EZ provides versatility to remove a wide range of pacing and defibrillation lead sizes.

"Controlling the entire lead length throughout the removal process is important for achieving safe and complete removal. The LLD technology gives me this control; it's a feature that other tools don't offer," said Dr. Laurence Epstein, Chief of Cardiac Arrhy
'/>"/>

SOURCE Spectranetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Spectranetics to Present at The A.G Edwards Growth Conference on September 18
2. Spectranetics to Appeal Decision in Patent Litigation
3. Spectranetics Receives Reimbursement Approval in Belgium for Lead Removal and Peripheral Atherectomy Products
4. Spectranetics to Hold 2007 Third Quarter Financial Results Conference Call on October 31
5. Spectranetics Announces Clinical Data From Cello Trial
6. Delta Dental of Illinois Introduces Smile Smart For Your Health
7. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
8. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
9. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
10. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
11. Triveris Introduces Personal Health Record with Built-in Health Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...r an Injunction in Federal Court to Reclaim Overti...swire-USNewswire/ -- Registered nurses for Riversi... Medical Center, filed a Fair Labor Standards Act ...y to stop the county from violating federal law go... are seeking to represent all 867 registered nurse...
(Date:12/2/2008)...ire-USNewswire/ -- Are you unhappy with your smile... are available? , , The Pennsylvania Dental...metic options exist to improve your smile. Your de...tory to determine a suitable option to help restor...tic dental options. , , , , To...
(Date:12/2/2008)...edical Center ranks No. 1 nationwide for the speed...g balloon angioplasty, according to the National C... (Vocus) December 2, 2008 -- UCSF Medi...th which heart attack patients are treated using b...iovascular Data Registry (NCDR). Cardiac balloon ...
(Date:12/2/2008)...Breast-Specific Gamma Imaging (BSGI) has,been pro... the diagnosis of,invasive lobular carcinoma (ILC... a molecular breast imaging technique that can see...er very early stage cancers. When compared to,mam...g (MRI), BSGI has the,greatest sensitivity for de...
Breaking Medicine News(10 mins):Health News:Riverside County Registered Nurses File a Lawsuit to Stop County's Violation of Federal Law 2Health News:Cosmetic Dentistry: A Beautiful Smile Is Not Far Away 2Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 2Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 3Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2
...can make a difference. //Three-quarters of physici...a new study says they could be wrong. The new rese...ve at relieving back pain. Physicians often get f...pe of bed is best for their lower back pain. Few s...
...he Commonwealth's restaurants, taverns, and nightc...liquor-store sales as the House and Senate conclud.../ Working until nearly midnight, lawmakers also ap...to spur shoppers to spend more, thereby pumping up...
...t on a bill that would a prescription drug benefit...the politically popular entitlement program in its...lined up in our favor," House Speaker Dennis Haste...erence in the Capitol. "The time is upon us. It's ...
...arin in reducing stroke among people with an irreg...rug ximelagatran appears to be as effective as war...ople at high risk of stroke because of its blood t...he drawbacks of warfarin include an increased risk...
Other Medicine News:Health News:Senate assures ban on smoking 2Health News:Senate assures ban on smoking 3Health News:Senate assures ban on smoking 4Health News:House heads for Medicare drug vote, 2Health News:House heads for Medicare drug vote, 3
(Date:12/1/2008)...te Ltd today announced the initiation of a Phase 1...ctive JAK2 inhibitor, in leading medical centers i...yelofibrosis (CIMF). , , The trial is desi...1518 in patients with CIMF and is expected to enro...y will assess the safety profile and evaluate the ...
(Date:12/1/2008)...ith ENB-0040 at Children,s Hospital, Health Scienc... Enobia Pharma, an emerging Canadia...apeutics for serious bone disorders, today announc...rogram for hypophosphatasia was dosed. Enobia is i... ENB-0040 for the treatment of this rare and often...
(Date:12/1/2008)... , , ROCHESTER, Minn., Dec. 1 /PRNewswire-...the use of the drug therapy etanercept ineffective...ation of the liver caused by excessive consumption...d in the December issue of Gastroenterology ( ht...LERT: Additional audio and video resources, includ...
(Date:12/1/2008)...swire-FirstCall/ -- Following a,Request for Propo...VA-based,third generation smallpox vaccine, Publ...f of the Canadian Department of National Defence, ... delivery of IMVAMUNE(R). , The Canadian au...,country,s bio-preparedness programme. , T...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3The impact of physical activity on weight bearing knee joint 2297 1The impact of physical activity on weight bearing knee joint 2297 2The impact of physical activity on weight bearing knee joint 2297 3Babies raised in bilingual homes learn new words differently than infants learning one language 2295 1Babies raised in bilingual homes learn new words differently than infants learning one language 2295 2Babies raised in bilingual homes learn new words differently than infants learning one language 2295 3Painful condition affecting kidney failure patients increases risk of death 2293 1Painful condition affecting kidney failure patients increases risk of death 2293 2Painful condition affecting kidney failure patients increases risk of death 2293 3APHA Urges President Bush Not To Veto CHIP 3B Were Only One Signature Away from Protecting the Health of Our Children 2291 1APHA Urges President Bush Not To Veto CHIP 3B Were Only One Signature Away from Protecting the Health of Our Children 2291 2
... WIRE)--Mar 26, 2007 - Inovio Biomedical Corp.,(AM...A vaccines and,a novel solid tumor ablation therap...s published a scientific paper prepared by,Inovio,...om a,non-human primate study of an investigational...omedical,s electroporation technology.,The paper, ...
...Outpatient Infusion Study in Patients with,Chronic...ican,College of Cardiology 56th Annual Scientific ... March 25, 2007,/PRNewswire/ -- Scios Inc. announc... study of nesiritide (NATRECOR(R)) showed a,neutra...eath and,cardiorenal hospitalization at 12 weeks, ...
Other Medicine Technology:Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 2Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 3Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7
...fely, the Hoefer GD 2000 uses a dry-heat vacuum me...through a heavy aluminum platen. , Dries acrylami...as thirty minutes., The heavy aluminum platen prov...bution under the gel., A clear silicone cover shee...
...ilizes a hot air drying device for polyacrylamide ...g frames at once. Gels are dried on a clear cellop...is recessed to provide a smooth, flat assembly sur...m includes a gel drying oven, 2 drying frames, 16 ...
The PRO6000 power supply is the latest edition to Thermo's power supply product offering. It sets new standards in proteomic and genomic electrophoresis. This product has unique features dedicated to
Capable of producing up to 500 volts and 500 milliamps, this power supply is ideal for PAGE, SDS-PAGE, DNA or RNA submarine gels as well as all types of small format transfer apparatus.
Medicine Products: